MAXIPIME Drug Patent Profile
✉ Email this page to a colleague
When do Maxipime patents expire, and when can generic versions of Maxipime launch?
Maxipime is a drug marketed by Hospira Inc and is included in one NDA.
The generic ingredient in MAXIPIME is cefepime hydrochloride. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Maxipime
A generic version of MAXIPIME was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MAXIPIME?
- What are the global sales for MAXIPIME?
- What is Average Wholesale Price for MAXIPIME?
Summary for MAXIPIME
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Clinical Trials: | 6 |
| Patent Applications: | 5,908 |
| Drug Prices: | Drug price information for MAXIPIME |
| DailyMed Link: | MAXIPIME at DailyMed |
Recent Clinical Trials for MAXIPIME
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yasser Esmat Mohammed | Phase 2/Phase 3 |
| Assiut University | Phase 2/Phase 3 |
| Accellena Research and Development | Phase 2 |
US Patents and Regulatory Information for MAXIPIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira Inc | MAXIPIME | cefepime hydrochloride | INJECTABLE;INJECTION | 050679-002 | Jan 18, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira Inc | MAXIPIME | cefepime hydrochloride | INJECTABLE;INJECTION | 050679-003 | Jan 18, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira Inc | MAXIPIME | cefepime hydrochloride | INJECTABLE;INJECTION | 050679-001 | Jan 18, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
